Status:
COMPLETED
Safety Study of XP12B in Women With Menorrhagia
Lead Sponsor:
Ferring Pharmaceuticals
Conditions:
Menorrhagia
Heavy Menstrual Bleeding
Eligibility:
FEMALE
18-49 years
Phase:
PHASE3
Brief Summary
The purpose of this study is to evaluate the safety of XP12B in women with heavy menstrual bleeding associated with menorrhagia.
Eligibility Criteria
Inclusion
- Women with menorrhagia
- 18-49 years of age
- Regularly occuring menstrual periods
Exclusion
- History or presence of clinically significant disease or abnormalities that might confound the study
- History of bilateral oophorectomy or hysterectomy
Key Trial Info
Start Date :
June 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2009
Estimated Enrollment :
784 Patients enrolled
Trial Details
Trial ID
NCT00113568
Start Date
June 1 2005
End Date
May 1 2009
Last Update
June 15 2010
Active Locations (59)
Enter a location and click search to find clinical trials sorted by distance.
1
Investigative Site
Birmingham, Alabama, United States, 35235
2
Investigative Site
Mobile, Alabama, United States, 36608
3
Investigative Site
Montgomery, Alabama, United States, 36106
4
Investigative Site
Phoenix, Arizona, United States, 85032